Thermo, Moderna ink COVID-19 vaccine manufacturing deal

By The Science Advisory Board staff writers

Moderna has signed a deal with Thermo Fisher Scientific to provide manufacturing services and supply packaging for its COVID-19 vaccine.

Under the agreement, Thermo's manufacturing site in North Carolina will be used for aseptic fill and finish, labeling, and packaging to support the production of hundreds of millions of doses of Moderna's vaccine. Production will start in the third quarter of 2021.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?